Peptide Dosing Chart for Tirzepatide

The peptide dosing chart for tirzepatide begins at 2.5 mg once weekly by subcutaneous injection. The dose typically increases every four weeks in 2.5 mg steps, up to a maximum of 15 mg weekly. Tirzepatide is a prescription-only medication, so this chart is a general guide—not a substitute for your healthcare provider's instructions.

What Is Tirzepatide and Why Does Dosing Matter?

Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). It is a synthetic peptide, which is why people search for a peptide dosing chart tirzepatide when planning or tracking treatment.

Dosing matters because tirzepatide can cause gastrointestinal side effects like nausea, vomiting, and diarrhea. Starting low and increasing slowly helps your body adjust. Skipping steps or jumping to a higher dose increases the risk of severe side effects.

The Standard Tirzepatide Dosing Chart

The FDA-approved schedule for tirzepatide uses a step-up approach. The table below shows the standard tirzepatide dosage chart for adults. Your clinician may keep you at a lower dose if it controls your blood sugar or weight effectively.

Step	Weekly Dose	Duration
1	2.5 mg	4 weeks
2	5 mg	4 weeks
3	7.5 mg	4 weeks
4	10 mg	4 weeks
5	12.5 mg	4 weeks
6	15 mg	Maximum dose

The 2.5 mg starting dose is for initiation only and is not intended for long-term glycemic control. Most people move to 5 mg after four weeks unless side effects are intolerable. Never increase your dose faster than your prescriber directs.

How to Read a Peptide Dosing Chart for Tirzepatide

A dosing chart is a tracking tool, not a prescription. When you look up a peptide dosing chart pdf online, check that it matches the manufacturer's official instructions. Tirzepatide comes in single-dose pens or vials, and the concentration varies by product.

Key things to verify on any chart:

• Units: Tirzepatide is measured in milligrams (mg), not micrograms (mcg) or "units" on an insulin syringe.
• Frequency: The standard schedule is once every 7 days. You can change the day of the week if needed, as long as at least 3 days pass between doses.
• Titration: Dose increases should happen no more often than every 4 weeks.
• Missed doses: If you miss a dose, take it within 4 days if possible. Otherwise, skip the missed dose and resume your regular schedule.

Many people also search for a aod-9604 peptide dosing chart or a lipo-c dosing chart while exploring other peptides. Those charts are not interchangeable with tirzepatide because the peptides have different mechanisms, half-lives, and approved uses.

Tirzepatide vs. Other Peptide Dosing Charts

Tirzepatide is not the same as wellness or research peptides like AOD-9604, Lipo-C, or MOTS-c. The table below compares typical dosing patterns, but only tirzepatide is FDA-approved for human use in the United States for its labeled indications.

Peptide	Common Purpose	Typical Dosing Frequency
Tirzepatide	Type 2 diabetes, weight management	Once weekly
AOD-9604	Fat metabolism (research/off-label)	Once daily
Lipo-C	Fat loss (compounded blends)	1–2 times weekly
MOTS-c	Metabolic research	5 days on, 2 days off

You may also see a mots-c peptide dosage chart female in online forums. Those resources address different peptides and should not be used to dose tirzepatide. Tirzepatide dosing is the same for most adults regardless of sex, though kidney or liver issues may change your prescriber's recommendations.

Safety and Medical Guidance for Tirzepatide

Tirzepatide is not FDA-approved for everyone. You should not use tirzepatide if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. It is also not recommended during pregnancy.

Common side effects include nausea, diarrhea, constipation, vomiting, and injection-site reactions. Serious side effects can include pancreatitis, gallbladder problems, and hypoglycemia when combined with insulin or sulfonylureas.

Always consult a licensed healthcare professional before starting, stopping, or changing your tirzepatide dose. A peptide dosing chart is only a reference—your prescription and medical history come first.

Call your healthcare provider right away if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction. These could be signs of pancreatitis or another serious condition.

Compounded tirzepatide is not FDA-approved and may not meet the same safety, quality, or efficacy standards as the brand-name products. If you use a compounded version, ask your pharmacist for a clear concentration and dosing instructions.

Key Takeaways for Your Tirzepatide Dosing Plan

• Tirzepatide is a prescription peptide, not an over-the-counter supplement.
• The standard starting dose is 2.5 mg once weekly for 4 weeks.
• Dose increases happen every 4 weeks, up to 15 mg weekly.
• Never double up on doses to make up for a missed injection.
• Store tirzepatide in the refrigerator according to the manufacturer's instructions.

COMMON QUESTIONS

Frequently Asked Questions

What is the starting dose of tirzepatide?

The standard starting dose of tirzepatide is 2.5 mg injected once weekly. This low dose helps your body adjust and is usually continued for four weeks before increasing to 5 mg. Some people stay at 2.5 mg longer if their provider recommends it.

How often can you increase your tirzepatide dose?

Tirzepatide doses are typically increased no more often than every four weeks. The dose goes up in 2.5 mg increments, from 2.5 mg to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg. Your healthcare provider may adjust the schedule based on your side effects and response.

Is tirzepatide a peptide?

Yes, tirzepatide is a synthetic peptide that acts on two hormone receptors: GIP and GLP-1. It is FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight management. It is not the same as research peptides like AOD-9604 or MOTS-c.